Abstract.-A multienzyme complex that catalyzes the anthranilate synthetase, phosphoribosylanthranilate (PRA) isomerase, and indoleglycerolphosphate (InGP) synthetase reactions was produced in vitro when extracts from a tryp-1 mutant and a tryp-2 mutant of Neurospora crassa were mixed. The sedimentation values and the molecular weights for the interacting components obtained from the mutants were estimated by sucrose gradients and by gel filtration on Sephadex columns. The component coded for by the tryp-2 gene (a-component) which is present in the tryp-1-17 mutant has a sedimentation coefficient of 4.5S and molecular weight of 70,000. The component coded for by the tryp-1 gene (i-component) which is present in the tryp-2-6 mutant has a sedimentation coefficient of 7.5S and a molecular weight of 170,000. The complex formed in vitro had similar properties to those previously reported for the wild-type complex. A Qio value of 3 and an apparent activation energy of 18,000 cal/mole were calculated for the formation of the complex from the two components.
Qio value of 3 and an apparent activation energy of 18,000 cal/mole were calculated for the formation of the complex from the two components.
A multienzyme complex which catalyzes three reactions in tryptophan biosynthesis in Neurospora crassa provides a relatively simple multicomponent protein which is particularly well suited for a study of the phenomena of recognition, interaction and assembly of distinct protein subunits. This complex possesses three activities, anthranilate synthetase, PRA isomerase and InGP synthetase, and is under the genetic control of two unlinked genes, tryp-1 and tryp-2.1 2 It has a molecular weight of approximately 240,000 and has been shown to be composed of six subunits af about 40,000 molecular weight each, two of which are responsible for the anthranilate synthetase activity and are specified by the tryp-2 gene, and 4 of which bear the active sites for the PRA isomerase and InGP synthetase activities and are specified by the tryp-1 gene.2' The active complex appears to be stable unless modified by certain chemical or physical agents.3 Because tryp-1 and tryp-2 mutants form components which have reduced sedimentation coefficients in sucrose gradients and which catalyze only one or two of the three reactions, we have suggested that mutations in either of the genes may block aggregation of the subunits and lead to the accumulation of individual components which are still active in some cases.2 When extracts from certain of these tryp-1 and tryp-2 mutants are mixed, a complex is formed with properties identical to those of the wild type. This system permits the study of the properties of the interacting components and the formation of the multionzyme complex.
Materials and Methods.-The tryptophan auxotrophs of N. crassa, tryp-1-17 and tryp-2-6, both mating type A, were employed in this study and have been previously described.2
The mutant tryp-1-17 produces very small amounts of anthranilate synthetase and lacks PRA isomerase and InGP synthetase activities, whereas the strain carrying the tryp-2-6 mutation lacks anthranilate synthetase activity and exhibits wild-type levels for the PRA isomerase and InGP synthetase activities. Procedures used for growing mycelia and for preparing crude extracts have been described previously.4 The concentrated extracts were prepared according to the procedure described by DeMoss and Wegman,' except that the concentration of ammonium sulfate was varied. The fraction precipitating at 0.0 to 0.5 saturation was used for the mutant tryp-1-17 and the fraction precipitating at 0.4 to 0.5 saturation was used for the mutant tryp-2-6. The precipitates were dissolved in a small volume of 0.05 M potassium phosphate buffer, pH 7.5, containing 0.1 mM EDTA and 0.1 mM DTT and were desalted on a G-25 Sephadex column with the same buffer.
Anthranilate synthetase activity was determined as described by DeMoss; Zone centrifugation experiments were carried out as follows. A 0.2-ml sample of a concentrated fraction and a 0.1-ml sample of a suspension of crystalline catalase (Worthington) was layered on 4.2 ml of a linear sucrose gradient (5-20% sucrose in 0.05 M potassium phosphate buffer, pH 7.5, containing 0.1 mM EDTA and 0.1 mM DTT).
Centrifugation was at 39,000 rpm for 11 hr in the SW-39 head in a Spinco model L centrifuge. The tubes were punctured at the bottom gnd approximately 24 fractions of ten drops each were collected. Each fraction was assayed for each of the appropriate activities and for catalase by measuring its absorbance at 405 nm. The approximate sedimentation coefficient for each component was estimated by comparing the position of the peak of each of the activities with the position of the peak of catalase. The sedimentation coefficient was estimated by assuming that it increased linearly from 0 to 11 between the top of the tube and the peak of the catalase.
The molecular weights were determined by measuring the elution volume on a calibrated Sephadex column as described by Whitaker.7 Sephadex G-100 and Sephadex G-200 were used for the a-and i-components, respectively. The reference proteins and molecular weights used were: bovine serum albumin, 68,000;8 catalase, 244,000;9 yeast alcohol dehydrogenase, 151,000;1O and ovalbumin, 45,000.11 Results.-It has been suggested that in Neurospora crassa the interaction of the products of the tryp-1 and tryp-2 genes is necessary for the expression of anthranilate synthetase activity." 2 Therefore, we attempted to study the interaction of these gene products in vitro by following the appearance of this activity. Accordingly, we selected two mutants which had little or no anthranilate synthetase activity and which were suspected of accumulating the products of the tryp-1 and tryp-2 genes respectively.2 Mutant tryp-1-17 completely lacks PRA isomerase and InGP synthetase activities but has very low levels of anthranilate synthetase activity with a sedimentation coefficient of approximately 7.5S, suggesting that at least some tryp-2 gene product is formed. Mutant tryp-2-6 produces no anthranilate synthetase activity but exhibits wild-type levels of PRA isomerase and InGP synthetase activities associated with a component with a sedimentation coefficient of approximately 7.5S. When crude extracts from these two mutants were incubated together for an hour at 5°C, a threefold increase in the total anthranilate synthetase activity was observed but no change in the levels of PRA isomerase or InGP synthetase activities occurred (Table 1) . Crude extracts were prepared as described in Methods and contained 4.5 mg protein per ml. The complementation mixture contained the appropriate amount of the extract, 0.05 M potassium phosphate buffer, pH 7.5, 0.1 mM EDTA, 0.1 mM DTT in a final volume of 1 ml. Incubation was carried out at 51C. After 1 hr, 0.1-ml aliquots were removed and assayed for all three activities as described in Methods.
In order to concentrate and partially purify the complementing activity present in each mutant extract, an ammonium sulfate fractionation was carried out on each extract. The results of mixing different fractions of the extract from one mutant with a concentrated extract from the other mutant are shown in Table 2 .
The complementing activity from the tryp-2-6 extract was precipitated at ammonium sulfate concentrations between 0.4 and 0.5 saturation. The complementing activity from the tryp-1-17 mutant precipitated in both fractions at ammonium sulfate concentrations of 0.0 to 0.4 and 0.4 to 0.5 saturation, and it appeared to be at least partially separable from the low level of anthranilate synthetase activity present in the 0.4 to 0.5 saturation fraction. The yield of anthranilate synthetase activity when the amount of tryp-1-17 extract was varied in the presence of a constant amount of tryp-2-6 extract is shown in Figure 1 .
The total anthranilate synthetase activity increased in proportion to the amount of the extract added. A similar result was obtained when the amount of tryp-2-6 extract was varied in the presence of a constant amount of tryp-1-17 extract; therefore, subsequent determinations of complementing activity from either mutant were performed in the presence of saturating amounts of the other required gene product.
In order to gain information concerning the size of the interacting components and the product of the interaction, we subjected the extracts of the mutants and the mixture to zone centrifugation. The complementing activity present in the tryp-1-17 mutant had a sedimentation constant of approximately 4.5S, while the low amount of anthranilate synthetase activity that was present in this mutant had a higher sedimentation constant of approximately 7.5S ( Fig. 2A) . The active complementing material in the tryp-2-6 mutant had a sedimentation constant of approximately 7.5S sedimenting at the same rate as the PRA isomerase and InGP synthetase activities present in this mutant (Fig. 2B) . The anthranilate synthetase activity that was formed when the partially purified fraction of the tryp-2-6 mutant was incubated in the presence of saturating amounts of the complementing material present in the tryp-1-17 mutant had a sedimentation constant of approximately 10S. Also, approximately 90 per cent of the PRA isomerase and InGP synthetase activities appeared to be associated with the 10S product (Fig. 2C) . These results indicate that an inactive 4.5S component present in the extract of tryp-1-17 and a 7.5S component which possesses PRA isomerase and InGP synthetase activities present in the extract of tryp-2-6 interact to form a lOS complex which catalyzes all the activities of the wild-type complex. Gel filtration experiments using calibrated Sephadex columns showed that the active complementing component present in the tryp-2-6 mutant which corresponds to the tryp-1 gene product had a molecular weight of approximately 170,000. This is designated the i-component. The component present in the tryp-1-17 mutant which corresponds to the tryp-2 gene product (a-component) had a molecular weight of approximately 70,000.
From the results of the sucrose gradient analysis, the product of the interaction of the i-and a-components appears to be identical in size to the wild-type complex. The following results indicate that other properties of the product are also identical to those of the wild-type complex. The Km values for chorismate and for CDRP exhibited by the complex formed in vitro are shown in Table 3 . The Km for chorismate is essentially identical to the value that has been previously reported4 and tenfold lower than the Km value obtained for the 7.5S
anthranilate synthetase activity present in the tryp-1-17 mutant.t The K* for complementing activities following zone centrifugation of (A) tryp-1-17 extract, (B) tryp-2-6 extract, and (C) the incubated mixture of these two extracts in a sucrose gradient prepared as described in Methods. 0.2 ml of the appropriate sample and 0.1 ml of catalase suspension were layered on each gradient. Centrifugation was for 11 hr at 39,000 rpm in the SW-39 head of the Spinco Model L. Ten-drop fractions were collected, diluted, and assayed. The complementing activity of the tryp-1 gene product was assayed in the presence of an excess of tryp-1-17 extract and the tryp-2 product was assayed in the presence of an excess of tryp-2-6 extract. The anthranilate synthetase, PRA isomerase, InGP synthetase, and the complementing activity were assayed as described in Methods. Incubation was carried out at the indicated temperatures. At appropriate times 0.1-ml aliquots were removed and assayed for the anthranilate synthetase activity as described in Methods.
CDRP shows a value similar to the wild-type value and clearly different from the Km exhibited by the i-component present in the tryp-2 mutant.
The rate of formation of anthranilate synthetase activity was sufficiently slow under the conditions utilized that the kinetics of the complementation reaction could be followed. The data in Figure 3A show that the complementation reaction is temperature-dependent; the initial rate of anthranilate synthetase formation at 20'C is ten times the rate at 0C. The Qio is approximately 3 and the apparent activation energy calculated from the Arrhenius plot of these data is approximately 18,000 cal/mole (Fig. 3B) .
Discussion.-These results demonstrate that the multienzyme complex which PROC. N. A. S.. catalyzes the anthranilate synthetase, PRA isomerase and InGP synthetase activities in Neurospora crassa can be formed in vitro from components accumulated by mutants. The previous failure to obtain in vitro complementation between tryp-1 and tryp-2 mutants which otherwise complement in vivo' can be attributed to utilizing the wrong mutants. Success in obtaining 'the in vitro formation of the complex apparently depends on selecting mutants which accumulate unaggregated tryp-1 and tryp-2 gene products.
The two interacting components appear to be similar to the two subunits which are generated from the purified wild type complex by pCMB treatments This treatment converts the complex to subunits containing dissimilar monomers, an inactive dimer (A2) and a tetramer (14) which possesses PRA isomerase and InGP synthetase activities. The a-component exhibits no enzymatic activities and has sedimentation and molecular weight values similar to the A2 fragment, and the i-component appears to possess PRA isomerase and InGP synthetase activities as well as sedimentation and molecular weight values similar to the I4 component.
It seems likely that the i-component (14) is the tryp-1 gene product since it is accumulated by mutant tryp-2-6 and it is apparently absent or altered in mutant tryp-1-17. Similarly, we assume that the a-component (A2) is the tryp-2 gene product. Furthermore, Chalmers12 has recently demonstrated that a-and icomponents are produced in altered forms by other tryp-2 and tryp-1 mutants, respectively.
The high activation energy for the over-all process implies that the interaction involves some fairly extensive rearrangements in the protein components. In addition, since this interaction occurs in the presence of a powerful reducing agent, the association of the components must not involve the formation of disulfide bridges.
The product of the interaction of the a-and i-components appears to be identical to the wild-type complex on the basis of its size and its kinetic properties. The sum of the estimated molecular weights of the a-and i-components is approximately equivalent to the molecular weight reported for the wild-type complex,3 suggesting that no other component of significant size is incorporated into the product. However, to determine whether any other factors are involved in the assembly process will require rigorous purification of the interacting components.
The amount of each interacting component present in the mutant extracts is approximately equal to the amount of the respective subunits present in the complex found in crude extracts of the wild type. Therefore, the assembly of the complex would appear to have little, if any, effect on the production of its subunit components. Rather, the two gene products must be produced independently and the interaction to form the multienzyme complex must occur as a subsequent reaction.
